Browse our articles
Browse by:
New Alzheimer's drug slows cognitive decline by 35 per cent
Donanemab has been shown to reduce cognitive decline in people with early-stage Alzheimer’s disease.
Nine in ten people want to know their brain disease risk
New research reveals that 91 per cent of people would take a simple test to learn about their risk
Research Champion Wendy Mitchell
Research Champion and Sunday Times best-selling author Wendy Mitchell shares her experience
